Virusähnliche Partikel – Impfstoffe, die den Eindringling imitieren

Virus-like particle vaccines have emerged as a promising and innovative approach to combat infectious diseases. Despite their immense potential as platform technology, challenges related to their production process need to be addressed to harness their full capabilities and make them widely assessible for human application.